Blog Post
LEN for PrEP: Lessons from Three Early Adopter Countries
Since December 2025, lenacapavir (LEN) for PrEP has been introduced in 10 African countries, hitting introduction milestones with record speed. AVAC, with support from the US Bureau of Global Health Security and Diplomacy (GHSD), partnered with Lvcthealth in Kenya, Pakachere Institute of Health and Development Communication in Malawi, and HEPS-Uganda, along with Ministries of Health (MoH) and the US Embassies in the three countries, to advance community-led demand generation, capacity-building and evidence-informed implementation to speed product introduction.